Targeting Hypoxic Prostate Tumors Using the Novel Hypoxia-Activated Prodrug OCT1002 Inhibits Expression of Genes Associated with Malignant Progression

Heather Nesbitt, Niall M. Byrne, S. Nicole Williams, Louise Ming, Jenny Worthington, Rachel J. Errington, Laurence H. Patterson, Paul J. Smith, Stephanie McKeown, Declan McKenna

Research output: Contribution to journalArticle

10 Citations (Scopus)
2 Downloads (Pure)

Fingerprint Dive into the research topics of 'Targeting Hypoxic Prostate Tumors Using the Novel Hypoxia-Activated Prodrug OCT1002 Inhibits Expression of Genes Associated with Malignant Progression'. Together they form a unique fingerprint.

Medicine & Life Sciences